Mapping spatially resolved transcriptomes in human and mouse pulmonary fibrosis
Nature Genetics
https://pubmed.ncbi.nlm.nih.gov/38951642/Lovisa Franzén # 1 2, Martina Olsson Lindvall # 1, Michael Hühn 3, Victoria Ptasinski 1, Laura Setyo 4, Benjamin P Keith 5, Astrid Collin 6, Steven Oag 6, Thomas Volckaert 7, Annika Borde 7, Joakim Lundeberg 2, Julia Lindgren 8, Graham Belfield 8, Sonya Jackson 9, Anna Ollerstam 1, Marianna Stamou 10, Patrik L Ståhl 11, Jorrit J Hornberg 1
1Safety Sciences, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden. 2Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden. 3Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. 4Pathology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK. 5Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden. 6Animal Science and Technology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden. 7Bioscience In Vivo, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. 8Translational Genomics, Centre for Genomics Research, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden. 9Late-Stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. 10Safety Sciences, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden. marianna.stamou@astrazeneca.com. 11Department of Gene Technology, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden. patrik.stahl@scilifelab.se. #Contributed equally.
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis and limited treatment options. Efforts to identify effective treatments are thwarted by limited understanding of IPF pathogenesis and poor translatability of available preclinical models. Here we generated spatially resolved transcriptome maps of human IPF (n = 4) and bleomycin-induced mouse pulmonary fibrosis (n = 6) to address these limitations. We uncovered distinct fibrotic niches in the IPF lung, characterized by aberrant alveolar epithelial cells in a microenvironment dominated by transforming growth factor beta signaling alongside predicted regulators, such as TP53 and APOE. We also identified a clear divergence between the arrested alveolar regeneration in the IPF fibrotic niches and the active tissue repair in the acutely fibrotic mouse lung. Our study offers in-depth insights into the IPF transcriptional landscape and proposes alveolar regeneration as a promising therapeutic strategy for IPF.
